MIV Therapeutics was founded in 2003 as BioSync India Pvt Ltd, on the simple premise that less-invasive medical device could improve patient care, was subsequently acquired by MIV Therapeutics Inc, Atlanta, U.S in September 2006 and established as MIV Therapeutics (I) pvt .ltd. In 2011, Purple Medical Solution Pvt. Ltd, acquired MIV Therapeutics (I) Pvt Ltd and now manage global operations. MIV Therapeutics (I) Pvt. Ltd. is a leader in the design and development of innovative vascular medical devices. We offer cardiovascular products, therapies and services that enhance or extend the lives of millions of people worldwide. MIV is a research and development company pursuing the commercialization of the next generation of biocompatible coatings for Stents and advanced drug delivery systems with the intent of providing healing solutions for cardiovascular disease. MIV has developed coating technologies that utilize Hydroxyapatite, polymer-free coatings and advanced polymeric coatings with enhanced biocompatibility and bioavailability for application on medical devices and drug delivery systems in Coordination with MIV Technologies Inc, Vancouver & British Columbia University.